A new partially hydrolyzed whey-based follow-on formula with age-adapted protein content supports healthy growth during the first year of life [PDF]
Frontiers in Pediatrics, 2022 BackgroundStandard infant formulae often have higher protein content than breastmilk in order to compensate for potentially lower digestibility; excess protein intake may promote adverse effects later in life. A new partially hydrolyzed whey-based (pHF-W)
Claude Billeaud +6 more
doaj +2 more sources
Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow‐on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V. [PDF]
EFSA Journal, 2023 The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from a whey protein concentrate and used in an infant and follow‐on formula manufactured by ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +21 more
doaj +2 more sources
Scientific and technical guidance for the preparation and presentation of a dossier for evaluation of an infant and/or follow‐on formula manufactured from protein hydrolysates (Revision 1) 1 [PDF]
EFSA Journal, 2021 Endorsement date 21 January 2021 Implementation date 27 March 2021 Following a request from the European Commission, EFSA was asked to provide scientific and technical guidance for the preparation and presentation of a dossierfor evaluation of an infant ...
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) +24 more
doaj +2 more sources
Baby food industry interference with infant feeding international regulation—A case study on the standard for follow-up formula [PDF]
Frontiers in Public Health, 2022 IntroductionGlobally, first-food systems have changed and breastfeeding has decreased due to the increased growth in commercial breast milk substitute (BMS) consumption, which includes both follow-up and toddler formulas.
Kimielle Cristina Silva +3 more
doaj +2 more sources
Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow‐on formula manufactured from hydrolysed protein by HIPP‐Werk Georg Hipp OHG (dossier submitted by meyer.science GmbH) [PDF]
EFSA Journal, 2022 The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from whey protein concentrate and used in infant and follow‐on formula by HIPP‐Werk Georg Hipp OHG.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +22 more
doaj +2 more sources
Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow‐on formula manufactured from hydrolysed protein by Danone Trading ELN B.V. [PDF]
EFSA Journal, 2020 The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from whey protein concentrate and used in an infant and follow‐on formula by Danone Trading ELN B.V, which
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +22 more
doaj +2 more sources
Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow‐on formula manufactured from protein hydrolysates [PDF]
EFSA Journal, 2017 Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide scientific and technical guidance for the preparation and presentation of applications for authorisation of infant ...
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) +24 more
doaj +2 more sources
Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co‐operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow‐on formula [PDF]
EFSA JournalThe European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability for use in infant and follow‐on formula of a specific protein hydrolysate from whey protein concentrate manufactured by Fonterra Co‐operative Group Ltd ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +18 more
doaj +2 more sources
Nutritional safety and suitability of a specific protein hydrolysate derived from sources of skimmed cow's milk and whey protein concentrates and used in infant and follow‐on formula manufactured from hydrolysed protein by Healthcare Reckitt B.V. [PDF]
EFSA JournalThe European Commission (EC) requested the European Food Safety Authority to evaluate the nutritional safety and suitability of a specific protein hydrolysate derived from sources of skimmed cow's milk (including non‐fat) and whey protein concentrates ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +18 more
doaj +2 more sources
Safety of oil from Schizochytrium limacinum (strain TKD‐1) for use in infant and follow‐on formula as a novel food pursuant to Regulation (EU) 2015/2283 [PDF]
EFSA Journal, 2023 Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of Schizochytrium sp. (TKD‐1) oil as a novel food (NF) pursuant to Regulation (EU) 2015/2283.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +28 more
doaj +2 more sources